The management of early ovarian cancer.
暂无分享,去创建一个
R. Ozols | B. Corn | R. Schilder | R. Young | R. Lanciano | Ozols Rf | M. Boente | Boente Mp | Russell J. Schilder | Boente Mp | Benjamin W. Corn | Lanciano Rm | Young Rc | Ozols Rf | Benjamin W. Corn | Lanciano Rm | Young Rc
[1] R. Ozols. Treatment of ovarian cancer: current status. , 1994, Seminars in oncology.
[2] Liu Sw,et al. [Prognostic factors in patients with stage I epithelial ovarian cancer]. , 1994, Zhonghua fu chan ke za zhi.
[3] T. Flotte,et al. Prognostic significance of DNA content in epithelial ovarian cancer. , 1994, Gynecologic oncology.
[4] P. Franzone,et al. High‐Risk Early‐Stage Ovarian Cancer Randomized Clinical Trial Comparing Cisplatin Plus Cyclophosphamide versus Whole Abdominal Radiotherapy , 1994, American journal of clinical oncology.
[5] M. Markman. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer. , 1994, Seminars in oncology.
[6] H. Averette,et al. Localized ovarian cancer in the elderly: The gynecologic oncology group experience , 2010, Cancer.
[7] R. Barakat,et al. Platinum‐based chemotherapy of high‐risk stage I epithelial ovarian cancer following comprehensive surgical staging , 1993, Obstetrics and gynecology.
[8] S. Rubin,et al. Second-Look Laparotomy in Stage I Ovarian Cancer Following Comprehensive Surgical Staging , 1993, Obstetrics and gynecology.
[9] I. Vergote,et al. Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second‐look laparotomy , 1993 .
[10] V. Abeler,et al. DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary , 1993, International Journal of Gynecologic Cancer.
[11] G. Fleuren,et al. Prognostic factors in well‐differentiated early‐stage epithelial ovarian cancer , 1993, Cancer.
[12] T. Tong,et al. Cancer statistics, 1993 , 1993, CA: a cancer journal for clinicians.
[13] A. Berchuck,et al. Comprehensive Restaging Laparotomy in Women With Apparent Early Ovarian Carcinoma , 1992, Obstetrics and gynecology.
[14] M. Piver,et al. Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy. , 1992, Gynecologic oncology.
[15] R. Schilder,et al. Management of early-stage ovarian cancer. , 1992, Hematology/oncology clinics of North America.
[16] A. Berchuck,et al. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging , 1992, Obstetrics and gynecology.
[17] V. Abeler,et al. Randomized trial comparing cisplatin with radioactive phosphorus or whole‐abdomen irradiation as adjuvant treatment of Ovarian cancer , 1992, Cancer.
[18] M. Parmar,et al. Early ovarian cancer and the icon trials. , 1992, European journal of cancer.
[19] M. E. Kirk,et al. Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. , 1991, Gynecologic oncology.
[20] P. Dottino,et al. A phase II trial of adjuvant cisplatin and doxorubicin in stage I epithelial ovarian cancer. , 1991, Gynecologic oncology.
[21] S. Rubin,et al. Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Berchuck,et al. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging , 1991, Cancer.
[23] L. Rubinstein,et al. Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications. , 1991, International journal of radiation oncology, biology, physics.
[24] G. Fleuren,et al. Watch and wait after careful surgical treatment and staging in well‐differentiated early ovarian cancer , 1991, Cancer.
[25] H. Malmström,et al. Phase I study of intraperitoneal carboplatin as adjuvant therapy in early ovarian cancer. , 1990, Gynecologic oncology.
[26] V. Abeler,et al. Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary. , 1990, Gynecologic oncology.
[27] I. Strøyer,et al. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. , 1990, Gynecologic oncology.
[28] M. Schemper,et al. Prognostic factors for survival in Stage I epithelial ovarian carcinoma , 1990 .
[29] S. Ellenberg,et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials , 1990, The New England journal of medicine.
[30] A. Stenwig,et al. Prognostic Factors in Patients With Stage I Epithelial Ovarian Cancer , 1990, Obstetrics and gynecology.
[31] A. Gadducci,et al. Adjuvant treatment of early stage ovarian carcinoma. , 1990, Clinical and experimental obstetrics & gynecology.
[32] M. Piver,et al. Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report. , 1989, Gynecologic oncology.
[33] J. Wils,et al. Chemotherapy Consisting of Cisplatin, Doxorubicin, and Cyclophosphamide as an Adjunct to Surgery in Stage Ic‐II Epithelial Ovarian Carcinoma , 1989, American journal of clinical oncology.
[34] R. Yazigi,et al. Primary staging in ovarian tumors of low malignant potential. , 1988, Gynecologic oncology.
[35] F. Macbeth,et al. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. , 1988, International journal of radiation oncology, biology, physics.
[36] R. Park,et al. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). , 1988, Gynecologic oncology.
[37] R. Peschel,et al. Postoperative abdominopelvic radiation therapy for ovarian cancer. , 1988, International journal of radiation oncology, biology, physics.
[38] O. Kallioniemi,et al. Prognostic significance of dna index, multiploidy, and S‐phase fraction in ovarian cancer , 1988, Cancer.
[39] S. Ellenberg,et al. Results of Second‐Look Laparotomy in Patients With Early‐Stage Ovarian Carcinoma , 1987, Obstetrics and gynecology.
[40] J. Baak,et al. Evaluation of the prognostic value of morphometric features and cellular DNA content in FIGO I ovarian cancer patients. , 1987, Analytical and quantitative cytology and histology.
[41] W. Sause,et al. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] H. Norris,et al. Misstaging of Ovarian Cancer , 1985, Obstetrics and gynecology.
[43] A. Stenwig,et al. EARLY STAGE OVARIAN CANCER , 1985, Acta obstetricia et gynecologica Scandinavica.
[44] A. Dembo. Radiotherapeutic management of ovarian cancer. , 1984, Seminars in oncology.
[45] B. Edwards,et al. Staging laparotomy in early ovarian cancer. , 1983, JAMA.
[46] Rosen Nb. Radioisotopes in the treatment of ovarian cancer. , 1983 .
[47] N. Rosenshein. Radioisotopes in the treatment of ovarian cancer. , 1983, Clinics in obstetrics and gynaecology.
[48] L. Lagasse,et al. The role of adjuvant therapy in Stage I ovarian cancer. , 1980, American journal of obstetrics and gynecology.
[49] J. Sturgeon,et al. Treatment of epithelial carcinoma of the ovary: operation, irradiation, and chemotherapy. , 1977, American journal of obstetrics and gynecology.
[50] T. J. Williams,et al. Status of the contralateral ovary in encapsulated low grade malignant tumors of the ovary. , 1977, Surgery, gynecology & obstetrics.
[51] Dockerty Mb,et al. Status of the contralateral ovary in encapsulated low grade malignant tumors of the ovary. , 1976 .
[52] L. Delclos,et al. Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy. , 1975, National Cancer Institute monograph.
[53] R. Symmonds,et al. Management of unilateral and encapsulated ovarian cancer in young women , 1973 .
[54] D. Decker,et al. Factors influencing survival in Stage I ovarian cancer , 1973 .
[55] G. Wilbanks,et al. Cancer of the ovary. Survival studies based upon operative therapy, chemotherapy, and radiotherapy. , 1970, American journal of obstetrics and gynecology.